T-cell response in human leishmaniasis.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Immunology Letters

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0165-2478(98)00132-1PMID 10065635
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High levels of plasma IL‐10 and expression of IL‐10 by keratinocytes during visceral leishmaniasis predict subsequent development of post‐kala‐azar dermal leishmaniasis

  1998cited by this paper
• Detection and characterization of Leishmania in tissues of patients with post kala-azar dermal leishmaniasis using a specific monoclonal antibody.

  1997cited by this paper
• The contrasting roles of CD4+ T cells in intracellular infections in humans: leishmaniasis as an example.

  1996cited by this paper
• Dichotomy of the T cell response to Leishmania antigens in patients suffering from cutaneous leishmaniasis; absence or scarcity of Th1 activity is associated with severe infections

  1995cited by this paper
• In vivo and in vitro cytokine profiles and mononuclear cell subsets in Sicilian patients with active visceral leishmaniasis.

  1995cited by this paper
• Dichotomy of the human T cell response to Leishmania antigens. I. Th1‐like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis

  1994cited by this paper
• Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2‐like response to gp63 and Thl‐like response to lipophosphoglycan‐ associated protein in cells from cured visceral leishmaniasis patients

  1994cited by this paper
• Thl‐Like Human T‐Cell Clones Recognizing Leishmania gp63 Inhibit Leishmania major in Human Macrophages

  1994cited by this paper
• Hemopoietic growth factors and mononuclear phagocytes

  1993cited by this paper
• In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma.

  1993cited by this paper
• Interleukin 10 production correlates with pathology in human Leishmania donovani infections.

  1993cited by this paper
• Potential role for interleukin-10 in the immunosuppression associated with kala azar.

  1993cited by this paper
• Cytokine patterns in the pathogenesis of human leishmaniasis.

  1993cited by this paper
• Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi.

  1992cited by this paper
• Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment.

  1992cited by this paper
• Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin 4 over interferon-gamma production.

  1990cited by this paper
• Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.

  1985cited by this paper
• Polyclonal B cell activation, circulating immune complexes and autoimmunity in human american visceral leishmaniasis.

  1984cited by this paper
• Immunosuppression in Kenyan visceral leishmaniasis.

  1983cited by this paper

• Relapse Kala-azar: A potential threat to sustaining public health elimination in Bangladesh and ways to overcome it

  2025cites this paper
• Thymic alterations resulting from experimental visceral leishmaniasis in a Syrian hamster (Mesocricetus auratus).

  2023cites this paper
• Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination

  2023cites this paper
• Potential Biomarkers for Asymptomatic Visceral Leishmaniasis among Iraq-Deployed U.S. Military Personnel

  2023cites this paper
• Deletion of MIF gene from live attenuated LdCen−/− parasites enhances protective CD4+ T cell immunity

  2023cites this paper
• Exploring drug repositioning for leishmaniasis treatment: Ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasis.

  2023cites this paper
• Host immunity and immunomodulation

  2021cites this paper
• Host immune response against leishmaniasis and parasite persistence strategies: A review and assessment of recent research.

  2021cites this paper
• Combinations of Iranian propolis and Leishmania proteins have the potential to influence IL-4 and IFN-γ in immunized Balb/c mice

  2020cites this paper
• Hemophagocytic lymphohistiocytosis associated with Leishmania: A hidden passenger in endemic areas.

  2020cites this paper
• Immune Response Profile in Susceptibility and Protection in Visceral Leishmaniasis

  2018cites this paper
• Drug Resistance in Leishmania Parasites

  2018cites this paper
• A recombinant chimeric protein composed of human and mice‐specific CD4+ and CD8+ T‐cell epitopes protects against visceral leishmaniasis

  2017cites this paper
• Leishmania infantum antigens modulate memory cell subsets of liver resident T lymphocyte.

  2017cites this paper
• Role of Cytokines in the Pathogenesis of Visceral Leishmaniasis.

  2017cites this paper
• A vaccine composed of a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection.

  2017cites this paper
• Canine leishmaniasis: the role of hepatocytes and Kupffer cells during Leishmania infantum infection

  2017cites this paper
• A vaccine combining two Leishmania braziliensis proteins offers heterologous protection against Leishmania infantum infection.

  2016cites this paper
• Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis.

  2016cites this paper
• Leptin induces the phagocytosis and protective immune response in Leishmania donovani infected THP-1 cell line and human PBMCs.

  2016cites this paper
• The immunology of post-kala-azar dermal leishmaniasis (PKDL)

  2016cites this paper
• Studies on Immunological Responses to Parasite Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis and Estimation of Asymptomatic Leishmania Infection in the Endemic Areas

  2016cites this paper
• Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs

  2016cites this paper
• Correction: Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis

  2015cites this paper
• Cytokine Release Assays as Tests for Exposure to Leishmania, and for Confirming Cure from Leishmaniasis, in Solid Organ Transplant Recipients

  2015influential citation
• A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis

  2015cites this paper
• Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis

  2015cites this paper
• Natural Products: Insights into Leishmaniasis Inflammatory Response

  2015cites this paper
• In vitro and in vivo evaluation of anti-leishmanial and immunomodulatory activity of Neem leaf extract in Leishmania donovani infection.

  2015cites this paper
• The immune response in patients with cutaneous leishmaniasis and the influence of zinc supplementation.

  2015cites this paper
• Leishmania donovani skews the CD56(+) Natural Killer T cell response during human visceral leishmaniasis.

  2015cites this paper
• Immune Regulation during Chronic Visceral Leishmaniasis

  2014cites this paper
• Immunostimulatory effects of Leishmania infantum HSP70 recombinant protein on dendritic cells in vitro and in vivo.

  2014cites this paper
• In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis

  2014cites this paper
• Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches

  2014cites this paper
• Cationic solid–lipid nanoparticles are as efficient as electroporation in DNA vaccination against visceral leishmaniasis in mice

  2013cites this paper
• Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs.

  2013cites this paper
• Vaccination as a Control Measure

  2013cites this paper
• "DURAÇÃO DA IMUNIDADE VACINAL NA LEISHMANIOSE VISCE RAL CANINA: PADRÃO DE CITOCINAS SINTETIZADAS POR LEUCÓCITOS CIRCULANTES APÓS ESTÍMULO IN VITRO COM ANTÍGENO SOLÚVEL DE Leishmania chagasi "

  2013cites this paper
• Imunofenótipos de linfócitos T no sangue e no liquor de cães com leishmaniose visceral: correlação com as lesões encefálicas

  2013cites this paper
• Leishmania parasite specific CD4 + synergizes and correlates positively with CD8 + T cells in the production of gamma interferon foll owing immunization of the vervet monkey (Chlorocebus aethiops) model

  2013cites this paper
• Association of IL18 gene polymorphisms (positions -656 G/T, -137 G/C and +105A/C) with Kala-Azar

  2012cites this paper
• Immunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccines

  2012influential citation
• Association of interleukin-18 gene variants with susceptibility to visceral leishmaniasis in Iranian population

  2012cites this paper
• Development of Leishmania vaccines: predicting the future from past and present experience

  2012cites this paper
• Therapeutic immunization with radio-attenuated Leishmania parasites through i.m. route revealed protection against the experimental murine visceral leishmaniasis

  2012cites this paper
• Development of Vaccines against Visceral Leishmaniasis

  2011cites this paper
• Immunity to Visceral Leishmaniasis

  2011cites this paper
• Innate immunity in transplant tolerance and rejection

  2011cites this paper
• Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human.

  2011cites this paper
• Charakterisierung der neutrophilen Granulozyten von suszeptiblen BALB/c- und resistenten C57BL/6-Mäusen im experimentellen Modell der Leishmaniasis

  2011cites this paper
• Cellular and humoral responses induced by Leishmania histone H2B and its divergent and conserved parts in cutaneous and visceral leishmaniasis patients, respectively.

  2010cites this paper
• Enhanced efficacy and immunogenicity of 78kDa antigen formulated in various adjuvants against murine visceral leishmaniasis.

  2010cites this paper
• Therapeutic Effect of Sodium Selenite and Zinc Sulphate as Supplementary with Meglumine Antimoniate( Glucantime®) Against Cutaneous Leishmaniasis In BALB/C Mice

  2010cites this paper
• Disseminated leishmaniasis caused by Leishmania tropica in HIV-positive patients in the Islamic Republic of Iran.

  2010cites this paper
• Vaccination with TAT-antigen fusion protein induces protective, CD8(+) T cell-mediated immunity against Leishmania major.

  2010cites this paper
• Allergen-sensitization in vivo enhances mast cell-induced inflammatory responses and supports innate immunity.

  2009cites this paper
• Immunophenotypic pattern and cytokine profiles of dry type cutaneous leishmaniasis.

  2009cites this paper
• Are neutrophils important host cells for Leishmania parasites?

  2009cites this paper
• Síndrome hemofagocítico secundario a leishmaniasis visceral

  2008cites this paper
• Vaccines for leishmaniasis in the fore coming 25 years.

  2008cites this paper
• Prophylactic Efficacy of High‐Molecular‐Weight Antigenic Fractions of a Recent Clinical Isolate of Leishmania donovani Against Visceral Leishmaniasis

  2008cites this paper
• [Hemophagocytic syndrome secondary to visceral leishmaniasis].

  2008cites this paper
• AVALIAÇÃO DA RESPOSTA IMUNE A VACINAS DE ANTÍGENO PARTICULADO DE Leishmania sp E SUA ASSOCIAÇÃO COM VACINA DE DNA pCI-neo-p36(LACK) EM CAMUNDONGOS BALB/c DESAFIADOS COM Leishmania chagasi

  2007cites this paper
• Interferon (IFN)-gamma , tumor necrosis factor-alpha , interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis.

  2006cites this paper
• Identification of Leishmania donovani antigens stimulating cellular immune responses in exposed immune individuals

  2006cites this paper
• Natural regulatory T cells and parasites: a common quest for host homeostasis

  2006cites this paper
• Animal models for vaccine studies for visceral leishmaniasis.

  2006cites this paper
• Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon‐γ and interleukin‐10 and low frequency of tumour necrosis factor‐α+ monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection

  2006cites this paper
• Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis.

  2006cites this paper
• Interferon (IFN)–γ, Tumor Necrosis Factor–α, Interleukin-6, and IFN-γ Receptor 1 Are the Major Immunological Determinants Associated with Post–Kala Azar Dermal Leishmaniasis

  2006cites this paper
• Interferon ( IFN ) – g , Tumor Necrosis Factor – a , Interleukin-6 , and IFN-g Receptor 1 Are the Major Immunological Determinants Associated with Post – Kala Azar Dermal Leishmaniasis

  2006cites this paper
• Tropical Infectious Diseases

  2006cites this paper
• Leishmania infantum-induced primary and challenge infections in rhesus monkeys (Macaca mulatta): a primate model for visceral leishmaniasis.

  2006cites this paper
• Genetically modified live attenuated parasites as vaccines for leishmaniasis.

  2006cites this paper
• HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS ASSOCIATED WITH VISCERAL LEISHMANIASIS: A Case Report

  2005cites this paper
• Mechanisms of the Natural Reactivity of Lymphocytes from Noninfected Individuals to Membrane-Associated Leishmania infantum Antigens1

  2005cites this paper
• Second-generation vaccines against leishmaniasis.

  2005cites this paper
• IMMUNOPATHOLOGY OF AUTOLEUKOCYTIC THERAPY OF CUTANEOUS LEISHMANIASIS

  2005cites this paper
• T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani.

  2005cites this paper
• Immune Response in Human Visceral Leishmaniasis: Analysis of the Correlation Between Innate Immunity Cytokine Profile and Disease Outcome

  2005cites this paper
• Dichotomy of protective cellular immune responses to human visceral leishmaniasis

  2005cites this paper
• Recent advances in vaccines for leishmaniasis

  2004cites this paper
• Estudo dos tipos e subtipos celulares predominantes e da expressão da enzima óxido nítrico sintase induzível (iNOS) na Paracoccidioidomicose Bucal

  2004cites this paper
• Genetics and visceral leishmaniasis in the Sudan: seeking a link.

  2004cites this paper
• Case report: effect of antileishmanial treatment on hepatitis C viraemia in a visceral leishmaniasis patient with chronic hepatitis C.

  2003cites this paper
• Cellular Profile of Cytokine Production in a Patient with Visceral Leishmaniasis: γδ+ T Cells Express Both Type 1 Cytokines and Interleukin‐10

  2003cites this paper
• Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid

  2003cites this paper
• Leishmania-specific lymphoproliferative responses and IgG1/IgG2 immunodetection patterns by Western blot in asymptomatic, symptomatic and treated dogs.

  2003cites this paper
• The role of CD4+CD25+ regulatory T cells in Leishmania infection

  2003cites this paper
• Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1

  2003cites this paper
• Development of a leishmaniasis vaccine: the importance of MPL

  2003cites this paper
• Acute renal failure as initial presentation of visceral leishmaniasis in an HIV-1-infected patient.

  2002cites this paper
• The effect of repeated leishmanin skin testing on the immune responses to Leishmania antigen in healthy volunteers.

  2002cites this paper
• IL-10 leads to a higher parasite persistence in a resistant mouse model of Leishmania major infection.

  2002cites this paper
• The African Green Monkey model for cutaneous and visceral leishmaniasis.

  2001cites this paper
• [Recent findings on the treatment of leishmaniasis].

  2001cites this paper
• IL‐10 mediates susceptibility to Leishmania donovani infection

  2001cites this paper
• An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine.

  2001cites this paper
• Cd4(+) T cell response to Leishmania spp. in non-infected individuals.

  2000cites this paper